Member Info for EmeraldCarrots

I N S A N E.

All IMHO.

If you knew another trust was placing an order.................... Will happen, just a matter of when IMHO. Then 2.5p plus easy IMHO. In fact up to just below the Chairmans buy level I would have thought....3.1p.

All IMHO.

JohnTerrySlipped.

"Didn't the insti's just chuck in £9M quid at 15p and yet they haven't sold going by the lack of TR1 updates. What do they know about Astrazeneca and Eisai?".

=============================

Good point. They clearly don't spend money unless there is an extremely good reason. In fact my impression is they don't invest enough! The science behind their orders must be sound. Both have a clear objective and have chosen Angle for good reason. Eisais' market cap is about $49 billion and Astra about $200 billion. They ain't daft!

Pharma or other Company IN THE WORLD catch circulating tumour cells from a std blood sample the are 99% alive and intact?????????????????????????????????????????????????????????????????????? END OF. The huge Pharma Co's risk a slightly smaller one taking our Angle for what ... 80p a share and then finding the slightly smaller one is now NOT slightly smaller.......... IT IS THERE FOR THE TAKING................ AT THE RIGHT PRICE.

All IMHO.

Swingman.

Pharmas "playing the odds"...... They can't deal with any risk these days, even if it costs them hundreds of millions in the long run. The people that make the decisions are weak. "we have nine contreacts with AGL now, and we will make x.". If we had bought them last year however we would be making x and reaping the rewards from all the other Pharma Co's the want our services...........

Sad.

All IMHO.

Catch circulating tumour cells (CTC's), 99% of them still alive and intact. No one can argue with that. It's easy in retrospect but the Company made a very serious error thinking the Pharma Co's would finance the assays (tests) that are needed to interrogate the CTC's and then the Parsortix machines would fly off the shelves. Massive, massive mistake. Few Pharma Co's were willing to spend the money creating the assays. I think this is wrong and has held back cancer research. The ones that looked into what they could do and then because of the cost of developing the assays did nothing should be ASHAMED OF THEMSELVES. It MUST have held back cancer research, and they are to blame. I suspect this has happened numerous times. I say again THEY SHOULD BE ASHAMED. Angle have now developed some state-of-the-art assays themselves, HER2, PD-L1 etc. Also, they have the dual analysis of CTCs and CtDna from a single blood sample that they are working on. All is not lost by a long chalk. I find it totally astonishing no large Pharma Co's have yet made an offer to buy Angle and get the Parsortix technology. I say this. Analysing circulating tumour cells is in it’s infancy. These huge Pharma Co’s are taking a huge risk that a discovery will be made that makes analysing live intact circulating tumour cells incredibly valuable.

All IMHO.

I've had better days. Late last night my central heating stopped working. Then this morning my stop loss on my oil bet was triggered aoubt 7:30am, then AGL's share price went down a shed load. Now I can't even have a drink because I may have to move my car later. FFS!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

So, when are Illumina going to bid for Angle Plc?........ How else can they get the Circulating tumour cells as well as the usual blood CtDna to do the DNA tests on and get the full picture? Come on, how??? So.. 85p a share?

All IMHO.

Https://www.bbc.co.uk/news/articles/crl8x6rr68zo

"This [test] means as soon as someone is diagnosed they can start treatment with a targeted therapy." !!!!!!!

This presumably is from Blood CtDna (Dead cancer cell DNA in the blood). Angle can do that PLUS analysing circulating tumour cells (CTC'S) in the blood at the same time ***to get the "full picture"***!! CtDna analysis alone can miss some mutated DNA that analysing CTC's picks up, so the cancer still can be targeted!

Ye ha!!!!!!!!!!

All IMHO.

Whilst sitting on the loo with my trousers around my ankles. The interims are already expected to be terrible, as the sp has sunk 35% from the placing they did just 3 months ago! Maybe I should have a bottle of Vodka to hand as well? LOL!!!!! I pray the interms will be ok.....

All IMHO.

- army chief. Also Gulf Of Mexico storm "Helene" is now a Hurricane.

Oil price likely to go up from here IMHO.

https://www.bbc.co.uk/news/live/c5y32qew9z2t

https://www.nhc.noaa.gov/index.shtml

A lot of action today with GDR!!

Https://www.nhc.noaa.gov/index.shtml

Over the next few days IMHO. Then what is drawing the sp up will become a block to get over!

All IMHO.

Up 20%

Co's can't catch circulating cancer cells of which 99% are still alive and intact perfect for testing as Angle can. With this "Next Generation Sequencing Assay Agreement with NUPROBE", see RNS below, Angle will be offering a unique service. A pan-cancer molecular sequencing assay either for CTC-DNA analysis alone or dual analysis of CTCs and CtDna from a single blood sample. Something no other Company in the World offers, or indeed can offer without the Angle's Parsortix machine to catch the alive and intact CTC's!

https://www.lse.co.uk/rns/AGL/exclusive-agreement-for-dna-ngs-panel-kjf10rvhdvv0bum.html

All IMHO.

Dibs61.

You sound like a combination of Moab and TwoGood2Die.

Maybe the 3 are just one?

Filtered. Bye!

JoeyBloggs7.

You have no clue, do you?

Challenge. He bought 1m shares @ 3.1p on 15th of this month. Expect the sp to rise rapidly to 3p ish though over the next few days, if not today.

Up 26%. 2.3p to buy at the moment.

All IMHO.

Price of 3.1p either today or in the next few days. Getting to and over the 3.1p will be a challenge.

Currently 2.25p to buy, up 26%.

All IMHO.